SHH and amyotrophic lateral sclerosis: Furthermore, aberrant Shh signaling has also been demonstrated to be involved in several brain pathologies, including cancer (e.g., medulloblastoma and glioma) [7,8] and CNS degenerative disorders (i.e., Parkinson’s disease and amyotrophic lateral sclerosis (ALS)) [9,10,11,12].